This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Multiple Sclerosis, Chronic Progressive
Information about Multiple Sclerosis, Chronic Progressive: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Multiple Sclerosis, Chronic Progressive
Most recent studies have shown that Multiple Sclerosis, Chronic Progressive shares some biological mechanisms with atrophy, autoimmune-diseases, autoimmune-reaction, cerebral-atrophy, cognition-disorders, demyelinating-diseases, demyelination, depressive-disorder, encephalomyelitis, impaired-cognition, inflammation, multiple-sclerosis, multiple-sclerosis-relapsing-remitting, nerve-degeneration, nervous-system-disorder, nervousness, primary-progressive-multiple-sclerosis, sclerosis, secondary-progressive-multiple-sclerosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Multiple Sclerosis, Chronic Progressive, and have been seen in publications frequently: Aging, Cell Activation, Cell Migration, Cell Proliferation, Cognition, Cytokine Production, Excretion, Humoral Immune Response, Immune Response, Inflammatory Response, Interferon-gamma Production, Localization, Neuroprotection, Pathogenesis, Reflex, Secretion, Segmentation, T Cell Activation, Translation, Transport
Quite a number of genes have been found to play important roles in Multiple Sclerosis, Chronic Progressive, such as ACAT1, CD4, CD8A, CSF2, CTLA4, IFNB1, IFNG, IL10, IL2, IL4, IL6, LAMC2, MBP, MOG, MTR, PPA1, PPY, SLC25A5, TFF2, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.